{
  "meta": {
    "title": "Pharmacology_Test_3",
    "url": "https://brainandscalpel.vercel.app/pharmacology-test-3-04b2b58c.html",
    "scrapedAt": "2025-11-30T07:33:20.299Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium binding resin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium gluconate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-month-old child presented to paediatric OPD with ambiguous genitalia, on investigation his BP is 110/70 mm Hg, Serum K is 6.5 mEq/L, serum sodium is 115 mEq/L. He was later started on intravenous fluids. What is the most specific therapy will you add to this patient immediately?</span></p>",
      "unique_key": "Q203033",
      "question_audio": null,
      "question_video": null,
      "map_id": 203033,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Normal serum K+ level </em></strong><strong><em>is <u>3.5-5.0 mEq/L</u>. </em></strong></p><p><strong><em>Normal Na+ level </em></strong><strong><em>is <u>136-152 mEq/L.</u></em></strong></p><p>So, the patient in the question has <strong><em>hyperkalemia and hyponatremia</em></strong>.</p><p>This together with ambiguous genitalia suggests the <strong><em>diagnosis of CAH (Congenital adrenal hyperplasia).</em></strong></p><p>In CAH, there is <em>deficiency of glucocorticoids and mineralocorticoids.</em></p><p><strong><em>Hydrocortisone is the glucocorticoid with maximum mineralocorticoid activity</em></strong>, so it is the preferred drug for treatment of this patient.</p><p><strong><u>Comparative features of different Corticosteroids</u></strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniIII11052024/1E.png\"><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Hydrocortisone. </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 314</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Canagliflozin</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosiglitazone</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Voglibose</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Rapaglinide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female named Maya with long standing history of type -II diabetes mellitus presented to ophthalmology department with complaints of decrease visual acuity after taking an anti-diabetic drug for some time. Fundus examination revealed features of macular edema (image below). Which of the following anti-diabetic drugs is implicated for the same?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniIII11052024/2Q.jpg\"></span></p>",
      "unique_key": "Q203034",
      "question_audio": null,
      "question_video": null,
      "map_id": 203034,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Thiazolidinediones</p><ul><li>Act as <strong><em>agonists of a nuclear receptor; peroxisome proliferator activated receptor gamma (PPAR</em></strong><strong><em>&gamma;</em></strong><strong><em>).</em></strong></li></ul><p>It <strong><em>regulates the transcription of genes involved in glucose and lipid metabolism</em></strong>. Important genes that are up <strong><em>regulated by PPAR-</em></strong><strong><em>&gamma;</em></strong> are:</p><ul><li><em>Adiponectin</em></li><li><em> Fatty acid transport protein</em></li><li><em> Insulin receptor substrate</em></li><li><em> GLUT - 4</em></li><li><strong> Rosiglitazone </strong><strong><em>increases total and LDL cholesterol </em></strong><strong><em>as well as HDL-cholesterol</em></strong> whereas pioglitazone increases HDL-cholesterol without affecting total and LDL-cholesterol.</li><li><strong> There were concerns of Pioglitazone </strong>to be associated with <strong>increased risk of bladder cancer </strong>on long term use.</li><li><strong> Both of these </strong>can result in:</li><li>Weight gain</li><li>Edema</li><li><strong><u>New onset or worsening of </u></strong><strong><u>macular edema</u></strong></li><li>Increase in fracture risk in women</li><li>Anemia</li></ul><p><strong>[Very important question]</strong></p><p><strong>Topic: Rosiglitazone </strong></p><p><strong>Reference:</strong> Goodman &amp; Gilman's The Pharmacological Basis of therapeutics 13<sup>th</sup> edition, page number. 877</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Unaltered</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Levothyroxine should be stopped</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26 years old female patient with history of hypothyroidism was stable on levothyroxine becomes pregnant. Which of the following statement regarding the dose of the levothyroxine for this pregnant patient is most accurate?</span></p>",
      "unique_key": "Q203035",
      "question_audio": null,
      "question_video": null,
      "map_id": 203035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><u>Adult hypothyroidism</u></strong></p><p>This is one of the <strong><em>commonest endocrine disorders which develops as a consequence of autoimmune thyroiditis or thyroidectomy</em></strong>.</p><p>Doses may be increased every 2&ndash;3 weeks to an optimum of 100&ndash;150 &mu;g/day (doses <strong><em>should be adjusted by clinical response as well as serum TSH and free T4 levels</em></strong>).</p><p>Further dose <strong><em>adjustments are made at 4&ndash;6 week intervals</em></strong> needed for reaching steady-state.</p><p>Individualization of proper dose is critical, <strong><u>aiming at normalization of serum TSH levels.</u></strong></p><p><strong><u>Increase in dose is mostly needed during pregnancy.</u></strong><p><strong>[Very important question]</strong></p><p><strong>Topic: levothyroxine dose in pregnancy.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 273</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">SGLT 2 inhibitors</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">DPP4 inhibitors</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">GLP 1 agonists</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfonylureas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old female named Soumya with long standing history of type -II diabetes mellitus presented to medicine OPD for treatment. She also gave family history of having medullary cancer of thyroid to her first degree relative. Which of the following group of anti-diabetic drug should be avoided in a patient with family history of medullary cancer of thyroid?</span></p>",
      "unique_key": "Q203036",
      "question_audio": null,
      "question_video": null,
      "map_id": 203036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>GLP-1 analogs are contraindicated in patients with a personal or family history of Medullary Thyroid Cancer or in patients with <u>Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).</u></em></strong></p><p><strong><u>GLP-1 analogs cause thyroid C-cell tumors at clinically relevant exposures in rodents.</u></strong></p><p>In clinical trials, <strong><em>patients treated with </em></strong><strong><em>liraglutide </em></strong><strong><em>and semaglutide had increased risk of gallbladder disease.</em></strong></p><p>The GLP-1 receptor is <u>expressed by thyroid C cells</u>. Although there is not an established clinical association with medullary carcinoma of the thyroid, <strong><em>GLP-1 agonists should not be given to these patients.</em></strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic: GLP 1 agonists in MTC family history patients </strong></p><p><strong>Reference:</strong> Goodman &amp; Gilman's The Pharmacological Basis of therapeutics 14<sup>th</sup> edition, page number. 1039</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium chloride</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium gluconate</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium carbonate</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium citrate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 years old male patient brought to emergency department with laryngospasm, severe carpopedal spasm and focal seizure. Later he diagnosed of having hypocalcemic tetany (image below). Which of the following preparation of calcium is most preferred for emergency treatment of hypocalcemia?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniIII11052024/5Q.jpg\"></span></p>",
      "unique_key": "Q203037",
      "question_audio": null,
      "question_video": null,
      "map_id": 203037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><u>Both calcium gluconate and calcium chloride</u></strong> can be given <strong><u>intravenously </u></strong>and indicated in<strong><u> the emergency management of hypocalcaemia.</u></strong></p><p><strong><em>Calcium chloride</em></strong> is freely water soluble but <u>highly irritating</u>.</p><p><strong><em><u>Calcium gluconate is less irritating and better tolerated</u></em></strong> than calcium chloride. Therefore, calcium gluconate is preferred.</p><p><strong>Option C &amp; D</strong>: <strong><em>Calcium carbonate and calcium citrate are <u>oral preparations</u> of calcium </em></strong></p><p><strong>[Very important question]</strong></p><p><strong><strong>Topic: Calcium gluconate in hypocalcemia </strong></strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 362</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">No increase in risk of venous thromboembolism</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">No increase in risk of endometrial hyperplasia/cancer</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be used in tamoxifen resistance advanced cases</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">All the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which amongst the following are advantages of aromatase inhibitors over tamoxifen for breast cancer treatment?</span></p>",
      "unique_key": "Q203038",
      "question_audio": null,
      "question_video": null,
      "map_id": 203038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Aromatase inhibitors dramatically reduce estrogen levels</em></strong> that translate to the following properties</p><ul><li><em>No increase in risk of venous thromboembolism</em></li><li><em>No increase in risk of endometrial hyperplasia/cancer.</em></li><li><em>It is <u>indicated in tamoxifen resistance</u> advanced cases also.</em></li></ul><p><strong><u>Letrozole/Anastrozole desirable features over </u></strong><strong><u>tamoxifen:</u></strong></p><ol><li><strong><em>Inhibits production of estrogens in all tissues</em></strong>. Nearly total estrogen deprivation.</li><li><strong><em>More effective in delaying recurrence of early stage breast Cancer</em></strong>. (adjuvant therapy).</li><li>Continues to exert <strong><em>prophylactic effect beyond 5 years.</em></strong></li><li><strong><em>Greater delay in disease progression and greater Survival advantage in palliative treatment of advanced/ metastatic breast Cancer.</em></strong></li><li><strong><em>Effective in tamoxifen failure cases</em></strong> of advanced breast Cancer.</li><li><strong><em>No endometrial hyperplasia</em></strong>/cancer predisposition</li><li><strong><em>No increase in thromboembolic risk</em></strong>.</li><li>No effect on lipid profile.</li></ol><p><strong>[Very important question]</strong></p><p><strong>Topic: Aromatase inhibitors over tamoxifen</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 339</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Phentolamine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenoxybenzamine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylephrine</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old sexually active male with long history of having erectile dysfunction went for treatment to a quack practitioner. He has been injected with Intracavernosal injection of papaverine that lead to priapism. Which of the following is the most accurate drug that has to be administered to reverse priapism?</span></p>",
      "unique_key": "Q203039",
      "question_audio": null,
      "question_video": null,
      "map_id": 203039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Priapism occurs due to excessive vasodilation</em></strong> caused by papaverine.</p><p><strong><em>Administering a vasoconstrictor like phenylephrine (or other alpha agonists) counteracts priapism.</em></strong></p><p><strong>Option A &amp; B</strong>: <strong><em>Phentolamine and phenoxybenzamine are alpha blockers that cause vasodilation and can worsen priapism.</em></strong></p><p><strong><u>Papaverine/Phentolamine Induced Penile Erection</u></strong></p><p><strong><u>(PIPE) therapy for impotence </u></strong></p><p>In patients unable to achieve erection, <em>injection of papaverine in the corpus cavernosum has been found to produce penile tumescence to permit intercourse.</em></p><p><strong><em>Priapism occurs in 2-15% cases</em></strong>, which if not promptly treated leads to permanent damage.</p><p><strong><em>Priapism is reversed by aspirating blood from the corpus cavernosum or by injecting phenylephrine locally.</em></strong></p><p><strong><u>Repeated injections can cause penile fibrosis. </u></strong></p><p>Other complications are-local haematoma, infection, paresthesia and penile deviation.</p><p><strong><em><u>Oral sildenafil is the preferred drug now.</u></em></strong></p><p><strong><em>PIPE therapy should be reserved for selected situations with proper facilities.</em></strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic: phenylephrine in priapism </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 157</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Clomiphene</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Ospemifene</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulipristal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old woman came to obstetrics department with infertility. Later she was diagnosed of having infertility due to anovulation. Which of the following agent is the most appropriate for this patient?</span></p>",
      "unique_key": "Q203040",
      "question_audio": null,
      "question_video": null,
      "map_id": 203040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Clomiphene is a SERM that interferes with negative feedback of estrogens on the hypothalamus</em></strong>, thereby <strong><em>increasing the secretion of gonadotropin-releasing hormone and gonadotropins</em></strong>, and leading to <u>stimulation of ovulation.</u></p><p><strong>Ospemifene</strong> is a SERM indicated for the <strong>treatment of dyspareunia.</strong></p><p><strong>Raloxifene</strong> is a SERM used in the <strong>prevention of breast cancer and osteoporosis</strong>.</p><p><strong>Ulipristal is a progesterone agonist/antagonist used as an emergency contraceptive.</strong></p><p><strong>[Previous year topic]</strong></p><p><strong>Topic:</strong> Clomiphene</p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 263</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethinyl estradiol/norgestimate</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Etonogestrel</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Levonorgestrel</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman requests emergency contraception after unprotected intercourse that occurred 1 day ago. She has no medical conditions. Which of the following agent is most appropriate for this patient?</span></p>",
      "unique_key": "Q203041",
      "question_audio": null,
      "question_video": null,
      "map_id": 203041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>A single dose of <strong><em>levonorgestrel is preferred for emergency contraception and should be administered within 72 hours of unprotected intercourse</em></strong> for best efficacy.</p><p><strong><em>Estrogen/progestin regimens are <u>less used for emergency contraception</u> due to a higher incidence of adverse effects</em></strong> such as nausea/vomiting.</p><p>Etonogestrel is a progestin used in the contraceptive ring and implant.</p><p><em><u>Mifepristone is a progesterone antagonist used to terminate pregnancy</u></em> once it has occurred.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: levonorgestrel in emergency contraception </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 348</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin glargine</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">NPH insulin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin lispro</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">NPH/regular 70/30 insulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male patient named Bikas with history of having type 2 diabetes currently being treated with insulin detemir by his physician. The physician determines that he needs additional insulin therapy for control of postprandial glucose. Which amongst the following agent is most appropriate to add at this time?</span></p>",
      "unique_key": "Q203042",
      "question_audio": null,
      "question_video": null,
      "map_id": 203042,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Insulin lispro is a rapid-acting insulin that has an onset of action within 15 to 30 minutes.</em></strong></p><p>Rapid-acting insulins are administered to <em><u>mimic the prandial (mealtime) release of insulin and control postprandial glucose levels.</u></em></p><p><strong><em>Insulin degludec is a long-acting insulin used to control fasting glucose levels.</em></strong></p><p><em>NPH insulin is an intermediate-acting insulin</em> also used for basal (fasting) control.</p><p><strong><em>NPH/regular 70/30 insulin is a mixture of NPH (intermediate-acting) and regular (short-acting) insulin.</em></strong></p><p>The patient is already on a long-acting insulin (detemir) for basal control, and another insulin for basal control is not warranted.</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniIII11052024/10E.png\"><p><strong>[Clinical question]</strong></p><p><strong>Topic: insulin lispro</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 289-290</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose of warfarin</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Replace warfarin with acenocoumarin</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch ethambutol for rifampicin</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Use LMWH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old diabetic female patient with history of active TB was on INH and rifampicin for the same. Later she brought to surgical department with signs of Deep Venous Thrombosis (DVT). She was started on warfarin, but Prothrombin time(PT) is not raised. Which of the following is most accurate step to be taken?</span></p>",
      "unique_key": "Q203043",
      "question_audio": null,
      "question_video": null,
      "map_id": 203043,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The <strong><em>anticoagulant effect of warfarin is assessed by the measurement of prothrombin time (PT).</em></strong></p><p>Failure of elevation of PT indicates the decreased effect of warfarin.</p><p><em><u>Rifampicin is an enzyme inducer and can decrease the effect of warfarin.</u></em></p><p>Rifampicin is the most effective drug for tuberculosis and should not be replaced.</p><p>Acenocoumarin is also an oral anticoagulant. Its metabolism is also subjected to induction by rifampicin.</p><p><strong><em>Effect of warfarin starts in 4-5 days. Therefore, if we increase the dose of warfarin, it will take 5 days to prevent DVT.</em></strong></p><p>For <strong><u>immediate action, heparin, or LMWH has to be started</u></strong>.</p><p><strong>[Clinical question]</strong></p><p><strong>Topic: LMWH in DVT.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 666</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoprecipitate</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet concentrate</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Fresh frozen plasma</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Packed red blood cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female patient was prescribed warfarin for prophylaxis of DVT. Later she presented with bleeding tendencies. Urgent reversal of warfarin induced bleeding can be done by the administration of which of the following agent?</span></p>",
      "unique_key": "Q203044",
      "question_audio": null,
      "question_video": null,
      "map_id": 203044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Treatment of warfarin induced bleeding:<strong><em> <u>Withhold the anticoagulant</u></em></strong></p><p><strong><em>Fresh frozen plasma (FFP)/fresh blood transfusions</em></strong>: <u>supplies the clotting factors immediately</u> and can be <strong><em>used as an urgent method of reversal of warfarin induced bleeding</em></strong></p><p><strong><em>Vitamin K1 is the specific antidote</em></strong> but it takes <strong><em>6-24 hours for the clotting factors to be resynthesized and released in </em>blood</strong> after Vitamin K administration.</p><p><strong><em>Cryoprecipitate mainly contains factor VIII and fibrinogen</em></strong> and therefore is <u>not suitable for warfarin induced bleeding as warfarin inhibits factor II, VII, IX, X.</u></p><p>Four factor prothrombin concentrate that contains human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C is considered superior over FFP and can be preferred if available.</p><p><strong>[Very important question]</strong></p><p><strong>Topic: Fresh frozen plasma in DVT.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 669</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Alteplase</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenecteplase</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Reteplase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following plasminogen activator can be administered as a single bolus dose for coronary thrombolysis?</span></p>",
      "unique_key": "Q203045",
      "question_audio": null,
      "question_video": null,
      "map_id": 203045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Single</em></strong><strong><em> IV bolus of tenecteplase is administered for coronary thrombolysis in Acute myocardial infarction.</em></strong></p><p>Alteplase is <strong><u>recombinant tissue-type plasminogen activator</u></strong> and is rapidly inhibited by plasminogen activator inhibitor-1 making it <strong><u>shorter acting</u>.</strong></p><p>Alteplase has to be <strong><u>administered as an infusion.</u></strong></p><p>Tenecteplase and reteplase are <strong>modified derivatives of recombinant tissue-type plasminogen activator</strong>. They are <u>resistant to inhibition by plasminogen activator inhibitor- 1.</u></p><p><strong><em>Reteplase can also be given as IV bolus dose, but the dose has to be repeated after 30 minutes.</em></strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic: coronary thrombolysis</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 674</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Prasugrel</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Ticagrelor</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Ticlopidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male patient with recent history of acute MI was prescribed an anti-platelet agent acting via P2Y12 inhibition. Later that patient came to medicine department with complaints of Dyspnea. Which of the following agent is commonly associated Dyspnea?</span></p>",
      "unique_key": "Q203046",
      "question_audio": null,
      "question_video": null,
      "map_id": 203046,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Ticagrelor is more commonly associated with dyspnea. </em></strong></p><p>The dyspnea is <strong><u>transient and not associated with pulmonary disease</u></strong>. Other Side effects are dizziness, nausea, <u>shortness of breath, tightness in chest</u> and irregular pulse.</p><p><strong><em>Dyspnea </em></strong>is <u>more commonly seen with reversible P2Y12 inhibitors like ticagrelor, cangrelor and elinogrel. </u></p><p>It is <strong><u>uncommon with irreversible P2Y12 inhibtors like clopidogrel, prasugrel and ticlopidine.</u></strong></p><p><strong>[Difficult]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic:Ticagrelor </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 679</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Unfractionated heparin</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Dalteparin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anticoagulant activity of which amongst the following agent is not affected by use of protamine sulfate?</span></p>",
      "unique_key": "Q203047",
      "question_audio": null,
      "question_video": null,
      "map_id": 203047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Protamine sulfate: </strong>It is a strongly <strong><u>basic, low molecular weight protein</u></strong> obtained from the sperm of certain fish.</p><p>Given intravenous, it neutralises heparin mg for mg, i.e. <strong><em>1 mg is needed for every 100 U of heparin. </em></strong></p><p><strong><em>Protamine is more commonly used when heparin action needs to be terminated rapidly</em></strong>, e.g. after cardiac or vascular surgery.</p><p>Protamine <strong><em><u>does not</u> neutralize fondaparinux</em></strong>, and it only <strong><em><u>partially</u> reverses the anticoagulant effect of LMW heparins.</em></strong></p><p><em>Protamine sulfate binds and neutralizes unfractionated heparin completely resulting in the complete reversal of both anti-factor Ila and Xa activity </em></p><p>Protamine sulfate <strong><u>reverses the anti-factor lla activity of LMWH completely</u></strong> and anti-factor Xa partially because the shorter chains cannot be neutralized.</p><p><strong>[Moderate]</strong></p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Protamine sulfate interaction with fondaparinux </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 666</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Clindamycin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Linezolid</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Lincomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 78-year-old female patient brought to emergency room with tachypnoea, difficulty in breathing, low oxygen saturation and high grade fever. On examination she was found to be having severe respiratory tract infection due to Staphylococcus aureus. On culture sensitivity, it was both methicillin resistant and vancomycin resistant. Which of the following is the most suitable antimicrobial agent that can be used to treat both MRSA & VRSA infection?</span></p>",
      "unique_key": "Q203048",
      "question_audio": null,
      "question_video": null,
      "map_id": 203048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Linezolid</strong></p><p>This is the first member of a new class of <strong><em>synthetic AMAs 'Oxazolidinones'</em></strong> useful in the <strong><em>treatment of <u>resistant</u> gram-positive coccal (aerobic and anaerobic) and bacillary infections. </em></strong></p><p>Linezolid is active against</p><ul><li><strong><em>MRSA </em></strong></li><li><strong><em>VRSA</em></strong></li><li><strong><em>VRE</em></strong></li><li><strong><em>Penicillin-resistant Pyogenes,</em></strong></li><li><strong><em> Viridians</em></strong><strong><em> and </em></strong></li><li><strong><em> pneumoniae.</em></strong></li></ul><p>It is <strong><em>primarily bacteriostatic</em></strong>, but can exert <strong><em>cidal action against some streptococci, pneumococci and B. fragilis.</em></strong></p><p><u>Gram-negative bacteria are not affected</u>.</p><p><strong>[Moderate]</strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic:Linezolid in MRSA&amp; VRSA infection </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 807</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Diethyl carbamazine citrate</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbetapentane</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Clomiphene citrate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female presented to pulmonary department with complaints of malaise, anorexia, weight loss, nocturnal cough and dyspnoea. On examination and investigation, her eosinophilic count was elevated with high Ig E levels in serum. Imaging study showed pulmonary infiltration as shown in the image below. Which of the following is the drug of choice for tropical pulmonary eosinophilia?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniIII11052024/17Q.jpg\"></span></p>",
      "unique_key": "Q203049",
      "question_audio": null,
      "question_video": null,
      "map_id": 203049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><u>Tropical pulmonary eosinophilia: </u></strong></p><p><strong>DEC </strong>(2-4 mg/kg TDS) for 2-3 weeks <strong><em>produces dramatic improvement in the signs and symptoms of eosinophilic lung or tropical eosinophilia.</em></strong></p><p>The benefit probably reflects <strong><em>anti-microfilarial action: the symptoms of the disease being presumably due to reaction to the Mf. </em></strong></p><p>The associated <strong><em>cough may respond to inhaled corticosteroids.</em></strong></p><p><strong>[Difficult]</strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic:Diethyl carbamazine citrate </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 911</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Amantadine</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Foscarnet</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Ritonavir</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Valacyclovir</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old nursing mother is diagnosed as suffering from genital herpes. She has a history of this viral infection. Previously, she responded to a drug used topically. Apart from her current problem, she is in good health. Which drug to be used orally is most likely to be prescribed at this time?</span></p>",
      "unique_key": "Q203050",
      "question_audio": null,
      "question_video": null,
      "map_id": 203050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Foscarnet, valacyclovir</em></strong> are <strong><em>active against strains of herpes simplex virus</em></strong>.</p><p><strong><em>Foscarnet </em></strong>is <strong><em>not used in genital infections (HSV-2)</em></strong> because clinical efficacy has not been established, it has <strong><em>poor oral bioavailability, and the drug causes many toxic effects.</em></strong></p><p><strong><em>Valacyclovir is converted to acyclovir</em></strong> by first-pass metabolism in the intestine and liver.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: valacyclovir in herpes</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 851</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">One day</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Three days</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Five days</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Seven days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Surgical antibiotic prophylaxis for clean elective surgery started just before operation should be continued for which of the following time?</span></p>",
      "unique_key": "Q203051",
      "question_audio": null,
      "question_video": null,
      "map_id": 203051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The selection of drug, dose, timing and duration of prophylactic medication is crucial.</p><p>It is important that the <strong><em>antibiotic is not started prematurely and is not continued beyond the time when bacteria have access</em></strong> to the surgical wound.</p><p><strong><em>Administration of the AMA has to be so timed that peak blood levels occur when clot is forming in the surgical wound</em></strong>, and it is present throughout the procedure.</p><p>Thus, <strong><em>most of the oral drugs are given <u>1 hour</u> before incision, while intravenous administration just before/after anaesthesia</em></strong> best ensures effective blood levels of the AMA during surgery.</p><p><strong>[Moderate]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic: surgical antibiotic prophylaxis </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 752-753</p>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Shigella enteritis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute bacterial endocarditis</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonorrhoea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">For which amongst the following infection Amoxicillin is inferior to Ampicillin for the treatment?</span></p>",
      "unique_key": "Q203052",
      "question_audio": null,
      "question_video": null,
      "map_id": 203052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Amoxicillin: </strong>It is a close <strong><em>congener of ampicillin</em></strong> (but not a prodrug); similar to it in all respects <strong><em>except:</em></strong></p><ul><li><strong><em>Oral absorption is better; food does not interfere with absorption</em></strong>; higher and more sustained blood levels are produced.</li><li>Amoxicillin given 3 times a day is equivalent to ampicillin given 4 times a day.</li><li><strong><em>Incidence of diarrhoea is lower</em></strong>.</li><li>It is <strong><em>less active against Shigella and H. influenzae.</em></strong></li><li>It is more active against relatively penicillin resistant <em>Strep. pneumoniae.</em></li></ul><p>Many physicians now <strong><em>prefer amoxicillin over ampicillin</em></strong> for <strong><em>bronchitis, urinary infections, SABE and gonorrhoea. </em></strong></p><p>It is a <strong><em>component of most triple drug </em></strong><strong><em>H. pylori eradication</em></strong> regimens.</p><p><strong>[Moderate]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic: Shigella enteritis treatment </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 773</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Levofloxacin</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Moxifloxacin</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Lomefloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male came to medicine department with complaints of having some infection and history of having mild renal impairment. His physician has prescribed him a fluoroquinolone. Which of the following fluoroquinolone does not require dose adjustment in a patient with creatinine clearance of &lt; 50 ml/min?</span></p>",
      "unique_key": "Q203053",
      "question_audio": null,
      "question_video": null,
      "map_id": 203053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Most </em></strong>of the available fluoroquinolones<strong><em> (</em><u>except moxifloxacin</u><em>) are cleared predominantly by kidneys</em></strong> and dosage need to adjusted in renal failure.</p><p><strong><em>Moxifloxacin is metabolized </em></strong>predominantly by the<strong><em> liver</em></strong> and should not be used in patients with hepatic failure.</p><p><strong><em>Moxifloxacin dose need not be adjusted in a patient with creatinine clearance &lt; 50 ml/min.</em></strong></p><p><strong><u>FQs safe in renal failure:</u></strong></p><ul><li><strong><u>Mnemonic </u></strong></li></ul><p><strong>P - Pefloxacin</strong></p><p><strong>M - Moxifloxacin</strong></p><p><strong>T - Trovafloxacin</strong></p><p><strong>Salient points: </strong></p><ul><li><strong><em>Safe in renal failure</em></strong></li><li><strong><em>Avoided in liver disease</em></strong></li><li><strong><em>Not effective in UTI</em></strong></li></ul><p><strong>[Difficult]</strong></p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Moxifloxacin in renal failure </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 764</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Norfloxacin</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Pefloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which amongst the following Fluoroquinolone that has high activity against M. leprae and is indicated in alternative multidrug therapy regimens for leprosy?</span></p>",
      "unique_key": "Q203054",
      "question_audio": null,
      "question_video": null,
      "map_id": 203054,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Ofloxacin has high activity against Mycobacterium leprae and Mycobacterium tuberculosis.</em></strong></p><p>It is indicated in several <u>alternative multidrug therapy regimens</u> for leprosy and is also utilized in the <u>management of resistant cases of tuberculosis</u>.</p><p><strong>Option B</strong>:</p><p>First generation drugs like <strong><em>norfloxacin have narrow spectrum</em></strong>.</p><p>The concentration of <strong><em>norfloxacin reached in urine is bactericidal</em></strong>, thus it <strong><u>can </u></strong><strong><u>be used for </u><em><u>UTI</u></em></strong> but it is <u>not effective for systemic use</u>.</p><p><strong>Option A: </strong></p><p>Ciprofloxacin is <strong><em>Second generation drug</em></strong>, effective against <strong><em>gonorrhoea and other gram negative organisms including pseudomonas. </em></strong></p><p><strong>Ciprofloxacin </strong>is the drug of choice for prophylaxis and treatment of<strong><em> anthrax and for prophylaxis of meningococcal meningitis</em></strong>.</p><ul><li><strong> <u>Ciprofloxacin and levofloxacin</u> </strong>are the only fluoroquinolones effective against <strong><em><u>Pseudomonas.</u></em></strong></li></ul><p><strong>Option D: </strong></p><p><strong>Pefloxacin</strong> is more lipid soluble, completely absorbed orally, penetrates tissues better and attains higher plasma concentrations.</p><p>Passage into <strong><em>CSF is greater than other </em>fluoroquinolones<em> - </em></strong>can be <strong><em>used for meningeal infections.</em></strong></p><p><strong>[Moderate]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic: Ofloxacin in leprosy </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page no. 763</p>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Azidothymidine</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Indinavir</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfamethoxazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male patient with AIDS was being treated with multiple drugs, including AZT, lamivudine, indinavir, keto-conazole, and cotrimoxazole. Later he came to medicine department with breast hypertrophy, central adiposity, hyperlipidemia, insulin resistance, and nephrolithiasis. If these side effects are related to his drug treatment, which of the following is the most likely implicated drug?</span></p>",
      "unique_key": "Q203055",
      "question_audio": null,
      "question_video": null,
      "map_id": 203055,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Indinavir, <strong><em>a protease inhibitor </em></strong>causes the above given adverse effects.</p><p>AIDS patients being treated with protease inhibitors (eg, <strong>indinavir</strong>) have developed a <strong><em>syndrome involving derangement of lipid metabolism</em></strong>.</p><p>This causes changes in <strong><em>body fat distribution and type 2 diabetes</em></strong> has also been reported.</p><p>It is often referred to as <strong><em>HIV/HAART-associated lipodystrophy</em></strong>.</p><p>It is typically seen after 6-12 months of protease inhibitor therapy.</p><p>Indinavir is also notable for its tendency to <strong><em>precipitate in the urinary tract, causing nephrolithiasis</em></strong>, unless the patient is maintained in a high state of hydration.</p><p><strong>[Moderate]</strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic:Indinavir </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 865</p>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefuroxime</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefoperazone</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftazidime</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefotaxime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 49-year-old female came to medicine department with complaints of having some abdominal infection with diarrhoea and lost appetite and history of having mild renal impairment. His physician has prescribed him a Cephalosporin. Which amongst the following Cephalosporin is most suitable as it does not require dose reduction in patient with renal failure?</span></p>",
      "unique_key": "Q203056",
      "question_audio": null,
      "question_video": null,
      "map_id": 203056,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Cephalosporins are usually excreted by glomerular filtration and tubular secretion. </em></strong></p><p>All cephalosporins need <strong><em>dose reduction in renal failure except<u> cefoperazone</u> that has predominant biliary excretion</em></strong>.</p><p><strong><u>Dose reduction is necessary for hepatic impairment for cefoperazone.</u></strong></p><p><strong>[Moderate]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic:cefoperazone </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 778</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptomycin</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyrazinamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old middle-aged man with chronic renal failure is diagnosed to have sputum-positive pulmonary tuberculosis. His creatinine clearance is 25 mL/min. Which of the following drug require no modification in dose at all with respect to renal impairment?</span></p>",
      "unique_key": "Q203057",
      "question_audio": null,
      "question_video": null,
      "map_id": 203057,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Rifampicin is metabolized to an active deacetylated metabolite in liver.</em></strong></p><p>Both the <strong><u>parent and active metabolites are primarily excreted in bile</u></strong>. Hence, Rifampicin dose adjustment is not needed in the above patient.</p><p><strong>Option A &amp; B: <em>Ethambutol and streptomycin are primarily excreted unchanged through the renal system</em></strong> and need dosage modification in renal failure.</p><p>The other first-line antitubercular agent, <strong><em>pyrazinamide, requires dosage reduction.</em></strong></p><p><strong>[Moderate]</strong></p><p><strong>[Very important question]</strong></p><p><strong>Topic: Rifampicin dosage in CRF.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 818</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}